Eurobio Scientific S.A.
ALERS.PA · PAR
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | €155 | €131 | €153 | €185 |
| % Growth | 18.6% | -14.4% | -17.4% | – |
| Cost of Goods Sold | €83 | €73 | €88 | €87 |
| Gross Profit | €72 | €57 | €65 | €97 |
| % Margin | 46.4% | 44% | 42.6% | 52.8% |
| R&D Expenses | €5 | €9 | €3 | €3 |
| G&A Expenses | €16 | €14 | €11 | €7 |
| SG&A Expenses | €45 | €34 | €31 | €24 |
| Sales & Mktg Exp. | €29 | €19 | €20 | €17 |
| Other Operating Expenses | -€0 | €5 | -€0 | -€2 |
| Operating Expenses | €50 | €47 | €34 | €25 |
| Operating Income | €13 | €10 | €31 | €72 |
| % Margin | 8.6% | 7.8% | 20.2% | 39% |
| Other Income/Exp. Net | €0 | -€3 | -€1 | €1 |
| Pre-Tax Income | €6 | €7 | €30 | €71 |
| Tax Expense | €2 | €2 | €5 | €11 |
| Net Income | €4 | €5 | €25 | €61 |
| % Margin | 2.6% | 3.7% | 16.3% | 32.8% |
| EPS | 0.39 | 0.43 | 2.2 | 5.58 |
| % Growth | -9.3% | -80.5% | -60.6% | – |
| EPS Diluted | 0.39 | 0.43 | 2.2 | 5.57 |
| Weighted Avg Shares Out | 10 | 11 | 10 | 11 |
| Weighted Avg Shares Out Dil | 10 | 11 | 10 | 11 |
| Supplemental Information | – | – | – | – |
| Interest Income | €3 | €1 | €0 | €0 |
| Interest Expense | €6 | €4 | €1 | €0 |
| Depreciation & Amortization | €8 | €13 | €10 | €8 |
| EBITDA | €20 | €25 | €40 | €80 |
| % Margin | 13.2% | 18.8% | 26.5% | 43.1% |